CLINICAL EFFICACY OF IMMUNOTHERAPY IN THE TREATMENT OF ATOPIC DERMATITIS IN CHILDREN

dc.contributor.authorНематова Х. Г.
dc.contributor.authorЮлдашов И. Р.
dc.date.accessioned2025-12-29T13:43:06Z
dc.date.issued2025-12-13
dc.description.abstractThe article presents the results of a study devoted to the optimization of the clinical efficacy of complex therapy for children with exacerbation of IgE-mediated atopic dermatitis by including an immunomodulator of microbial origin - glucosaminylmuramyl dipeptide.
dc.formatapplication/pdf
dc.identifier.urihttps://webofjournals.com/index.php/12/article/view/5611
dc.identifier.urihttps://asianeducationindex.com/handle/123456789/20859
dc.language.isoeng
dc.publisherWeb of Journals Publishing
dc.relationhttps://webofjournals.com/index.php/12/article/view/5611/5634
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0
dc.sourceWeb of Scientists and Scholars: Journal of Multidisciplinary Research; Vol. 3 No. 12 (2025): WOSS; 15-19
dc.source2938-3811
dc.subjectAtopic dermatitis, traditional therapy, immunotherapy, muramyl dipeptides, clinical efficacy, lycopid.
dc.titleCLINICAL EFFICACY OF IMMUNOTHERAPY IN THE TREATMENT OF ATOPIC DERMATITIS IN CHILDREN
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Article

item.page.files

item.page.filesection.original.bundle

pagination.showing.labelpagination.showing.detail
loading.default
thumbnail.default.alt
item.page.filesection.name
untitled_2025_clinical_efficacy_of_immunotherapy_in_th.pdf
item.page.filesection.size
239.58 KB
item.page.filesection.format
Adobe Portable Document Format

item.page.collections